Veryan Endovascular

Indonesia
Tangkanpulit, West Nusa Tenggara, Indonesia

Company profile

Veryan Endovascular company profile

Veryan Medical is a medical device company based in Galway. Veryan has recruited an experienced team of medical device professionals to commercialise its unique BioMimics 3D stent technology. The company recently secured a €5m venture capital investment led by Seroba Kernel Life Sciences and Imperial Innovations Group. The stent platform aims to mimic the natural shape and geometry of the human vascular system. It involves transposing a 3D helical shape onto a traditional straight stent. Pre-clinical studies have shown that BioMimics3D stents are more flexible, more kink resistant and more fracture resistant than straight stents. They also impart a swirling flow of blood through the stent, which has been shown to reduce restenosis (the re-narrowing of stented arterial segments). Veryan have completed human clinical trials and expect to CE Mark the product during 2012.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
51-100 employees

Headquarters

Country code
ID
Continent
Asia

Capital profile

Funding and company signals

No public funding data is available for this company.

Categories and groups

Founders and investors

No public relation records are available.